EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Progress of metabolomics‐centric multi‐omics research in medicine

Ziyi Wang iD, Shiwen Deng, Xiaoxu Wang, Xiao Chang, Na Guo, Peng Chen iD, Hongjun Yang

iMetaOmics · 2026-06 · 3 (2)

DOI: 10.1002/imo2.70096 ↗

At a glance

Übersichtsarbeit in iMetaOmics, published online on 2026-04-14. Written by Ziyi Wang and 6 co-authors. Institution: Experimental Research Center China Academy of Chinese Medical Sciences Beijing China. Cited 6 times so far (Crossref); 191 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolomics reveals molecular changes at the metabolic level during biological processes. Recent advancements, particularly through integration with other omics and artificial intelligence (AI), are advancing metabolic data analysis and multi‐omics interpretation. This review introduces a “metabolomics‐centric” paradigm as a conceptual framework for multi‐omics integration, positioning metabolic readouts as the functional anchor for interpreting genotype‐phenotype relationships. It also chronicles the evolution and medical applications of integration technologies. Our discussion first traces the field's evolution from bulk to single‐cell and spatial methodologies, next surveys integration strategies to uncover mechanistic insights, and finally examines how AI‐driven multimodal data integration and AI‐optimized metabolomics workflows tackle persistent biological and computational challenges. Looking forward, this review identifies the AI virtual cell as a pivotal future direction for metabolomics‐based multi‐omics integration, calling for increased attention to its development to simulate dynamic molecular phenotypic networks within a multi‐omics context.

Subjects

Author keywords

artificial intelligencemedical researchmetabolomicsmulti‐omics integrationvirtual cell

Authors and institutions

  • Experimental Research Center China Academy of Chinese Medical Sciences Beijing China.
  • AstraZeneca Pharmaceuticals LP Gaithersburg Maryland USA.
  • Department of Urology, The Third Medical Center Chinese People's Liberation Army (PLA) General Hospital Beijing China.
  • Analysis of complex effects of proprietary Chinese medicine Hunan Provincial Key Laboratory Yongzhou Hunan Province China.

ORCID profiles: Ziyi Wang, Peng Chen

Funding

  • National Natural Science Foundation of China

Cite

APA

Wang, Z., Deng, S., Wang, X., Chang, X., Guo, N., Chen, P., & Yang, H. (2026). Progress of metabolomics‐centric multi‐omics research in medicine. iMetaOmics, 3(2). https://doi.org/10.1002/imo2.70096

Vancouver

Wang Z, Deng S, Wang X, Chang X, Guo N, Chen P, et al. Progress of metabolomics‐centric multi‐omics research in medicine. iMetaOmics. 2026;3(2). doi:10.1002/imo2.70096

BibTeX
@article{Wang2026,
  author = {Wang, Ziyi and Deng, Shiwen and Wang, Xiaoxu and Chang, Xiao and Guo, Na and Chen, Peng and Yang, Hongjun},
  title = {Progress of metabolomics‐centric multi‐omics research in medicine},
  journal = {iMetaOmics},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.1002/imo2.70096}
}
Start for free →